It has been about a month since the last earnings report for Jazz Pharmaceuticals (JAZZ). Shares have lost about 9.2% in that time frame, underperforming the S&P 500. Will the recent negative trend ...

Envestnet Portfolio Solutions Inc. raised its stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 19.0% in the 4th quarter, according to its most recent filing with the SEC. The fund ...

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in the 24th Annual Needham Healthcare Conference. Company management ...

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in the 24th Annual Needham Healthcare Conference. Company management will participate in a fireside chat on ...

Bank of America Securities analyst Jason Gerberry reiterated a Buy rating on Jazz Pharmaceuticals (JAZZ – Research Report) today and set a ...

Dublin, Ireland-based Jazz Pharmaceuticals is a specialty biopharmaceutical company with a focus on neuroscience and oncology. JAZZ is a #2 (Buy) on the Zacks Rank, with a VGM Score of A.

The headbands were out on Wednesday in Memphis. All but one member of the Utah Jazz sported white NBA headbands for its game ...

An icon of 3 horizontal dots. An icon of a paper envelope. An icon of a facebook f logo. An icon of a digital camera. An icon of a house. An icon of the Instagram logo. An icon of the LinkedIn logo.

Markkanen (back) is questionable for Wednesday's game against Memphis.